3/26
07:00 am
dftx
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
Low
Report
Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
3/25
05:37 am
dftx
A Look At Definium Therapeutics (DFTX) Valuation After Its Recent Name Change And Share Price Momentum [Yahoo! Finance]
Medium
Report
A Look At Definium Therapeutics (DFTX) Valuation After Its Recent Name Change And Share Price Momentum [Yahoo! Finance]
3/25
01:44 am
dftx
Definium Therapeutics Inc (DFTX) Says Cash Enough to Fund Operations into 2028 [Yahoo! Finance]
Medium
Report
Definium Therapeutics Inc (DFTX) Says Cash Enough to Fund Operations into 2028 [Yahoo! Finance]
3/18
11:42 am
dftx
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]
Low
Report
This $6 Million Bet Adds a Brain Health Biotech to Portfolio Dominated by Clinical Stage Names [Yahoo! Finance]
3/15
06:09 am
dftx
Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]
Low
Report
Definium Therapeutics Teases Phase III DT120 Data for Anxiety, Depression at Leerink Conference [Yahoo! Finance]
3/9
04:01 pm
dftx
Definium Therapeutics Announces New Employee Inducement Grants
Medium
Report
Definium Therapeutics Announces New Employee Inducement Grants
3/2
09:04 am
dftx
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
Low
Report
Definium Therapeutics (DFTX) had its price target raised by HC Wainwright from $55.00 to $70.00. They now have a "buy" rating on the stock.
2/28
03:23 pm
dftx
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
Low
Report
Definium Therapeutics Weighs Breakthrough Status Against Valuation And Trial Risks [Yahoo! Finance]
2/26/2026
04:01 pm
dftx
definium therapeutics, inc. - common shares
MISS
Report
0.9%
definium therapeutics, inc. - common shares
3/26
06:43 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Karlin Daniel
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Karlin Daniel
3/26
06:43 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Sullivan Mark
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Sullivan Mark
3/26
06:42 pm
dftx
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Barrow Robert
Medium
Report
Form 4 Definium Therapeutics, For: Mar 25 Filed by: Barrow Robert
3/25
05:41 pm
dftx
Form 144 Definium Therapeutics, Filed by: Barrow Robert
Low
Report
Form 144 Definium Therapeutics, Filed by: Barrow Robert
3/25
05:40 pm
dftx
Form 144 Definium Therapeutics, Filed by: Karlin Daniel
Low
Report
Form 144 Definium Therapeutics, Filed by: Karlin Daniel
3/25
05:40 pm
dftx
Form 144 Definium Therapeutics, Filed by: Sullivan Mark
Low
Report
Form 144 Definium Therapeutics, Filed by: Sullivan Mark
2/26
04:25 pm
dftx
Form 10-K Definium Therapeutics, For: Dec 31
Low
Report
Form 10-K Definium Therapeutics, For: Dec 31
2/26
04:15 pm
dftx
Form 8-K Definium Therapeutics, For: Feb 26
Low
Report
Form 8-K Definium Therapeutics, For: Feb 26
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register